{"id":1538,"date":"2016-11-16T11:48:41","date_gmt":"2016-11-16T11:48:41","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=1538"},"modified":"2025-05-05T10:21:59","modified_gmt":"2025-05-05T04:51:59","slug":"the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time","title":{"rendered":"CRISPR gene-editing tested in a person for the first time"},"content":{"rendered":"<h2>\u00a0<\/h2>\n<p style=\"text-align: justify;\">A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR\u2013Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.\u00a0 The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world. However, this move by Chinese scientists could spark a biomedical duel between China and the United States.<\/p>\n<p>\u00a0<\/p>\n<p>To know more, click on the link below:<br \/>http:\/\/www.nature.com\/news\/crispr-gene-editing-tested-in-a-person-for-the-first-time-1.20988<\/p>\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR\u2013Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1539,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[41],"tags":[648,647,204,365,381],"industry":[17225],"therapeutic_areas":[17235,17228],"class_list":["post-1538","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-snippets","tag-analysis","tag-crispr","tag-delveinsight","tag-lung-cancer","tag-market-research","industry-pharmaceutical","therapeutic_areas-cell-and-gene-therapy","therapeutic_areas-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CRISPR&#039;s First Human Trial | CRISPR\u2013Cas9 Technique Latest Updates<\/title>\n<meta name=\"description\" content=\"A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR \u2013 Cas9 technique.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRISPR&#039;s First Human Trial | CRISPR\u2013Cas9 Technique Latest Updates\" \/>\n<meta property=\"og:description\" content=\"A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR \u2013 Cas9 technique.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-16T11:48:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T04:51:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/11\/12065831\/crispr.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1012\" \/>\n\t<meta property=\"og:image:height\" content=\"569\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CRISPR's First Human Trial | CRISPR\u2013Cas9 Technique Latest Updates","description":"A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR \u2013 Cas9 technique.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time","og_locale":"en_US","og_type":"article","og_title":"CRISPR's First Human Trial | CRISPR\u2013Cas9 Technique Latest Updates","og_description":"A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR \u2013 Cas9 technique.","og_url":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2016-11-16T11:48:41+00:00","article_modified_time":"2025-05-05T04:51:59+00:00","og_image":[{"width":1012,"height":569,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/11\/12065831\/crispr.png","type":"image\/png"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time","url":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time","name":"CRISPR's First Human Trial | CRISPR\u2013Cas9 Technique Latest Updates","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/11\/12065831\/crispr.png","datePublished":"2016-11-16T11:48:41+00:00","dateModified":"2025-05-05T04:51:59+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR \u2013 Cas9 technique.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/the-snippet-crispr-gene-editing-tested-in-a-person-for-the-first-time#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/11\/12065831\/crispr.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/11\/12065831\/crispr.png","width":1012,"height":569},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/11\/12065831\/crispr-300x169.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Snippets - A Small piece of News or Article<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Analysis<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">CRISPR<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Lung Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/snippets\/\" class=\"advgb-post-tax-term\">Market Research<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Analysis<\/span>","<span class=\"advgb-post-tax-term\">CRISPR<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>","<span class=\"advgb-post-tax-term\">Lung Cancer<\/span>","<span class=\"advgb-post-tax-term\">Market Research<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 9 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Nov 16, 2016","modified":"Updated on May 5, 2025"},"absolute_dates_time":{"created":"Posted on Nov 16, 2016 11:48 am","modified":"Updated on May 5, 2025 10:21 am"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1538","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=1538"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1538\/revisions"}],"predecessor-version":[{"id":31620,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1538\/revisions\/31620"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/1539"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=1538"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=1538"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=1538"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=1538"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=1538"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}